DELAY TO DIAGNOSIS IN JUVENILE SLE (JS']JSLE) PATIENTS: PRELIMINARY DATA FROM THE UK JS']JSLE COHORT STUDY

被引：0
|
作者：
Pain, Clare [2 ]
Gardner-Medwin, Janet [3 ]
McDonagh, Janet [4 ]
Pilkington, Clarissa [5 ]
Satyapal, Rangaraj [6 ]
Tizard, Jane [8 ]
Wilkinson, Nick [7 ]
Beresford, Michael W. [1 ]
机构：
[1] Univ Liverpool, Inst Child Hlth, Liverpool L69 3BX, Merseyside, England
[2] Alder Hey Childrens NHS Fdn Trust, Dept Rheumatol, Liverpool, Merseyside, England
[3] Royal Hosp Sick Children, Dept Rheumatol, Glasgow G3 8SJ, Lanark, Scotland
[4] Birmingham Childrens Hosp, Dept Rheumatol, Birmingham, W Midlands, England
[5] Great Ormond St Hosp Sick Children, Dept Rheumatol, London, England
[6] Queens Med Ctr, Dept Rheumatol, Nottingham NG7 2UH, England
[7] Nuffield Orthopaed Ctr, Dept Rheumatol, Oxford OX3 7LD, England
[8] Bristol Royal Hosp Children, Dept Nephrol, Bristol, Avon, England
来源：
RHEUMATOLOGY | 2009年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I46 / I46
页数：1
相关论文
共 50 条
  • [31] Monocyte Chemoattractant Protein 1 is expressed from kidney epithelial cells in Juvenile-onset Systemic Lupus Erythematosus (JS']JSLE)
    Watson, Louise
    Midgley, Angela
    Ballantine, Lucy
    Jones, Caroline
    Holt, Richard
    Marks, Stephen
    Pilkington, Clarissa
    Tullus, Kjell
    Beresford, Michael W.
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1686 - 1687
  • [32] Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study
    Eve M. D. Smith
    Peng Yin
    Andrea L. Jorgensen
    Michael W. Beresford
    Pediatric Rheumatology, 16
  • [33] Sensitivity of 2019 EULAR/ACR SLE Criteria and Initial Organ Manifestations for Black and Hispanic Children with Juvenile Systemic Lupus Erythematosus (jS']jSLE) at a Large Tertiary Care Center
    Butts, Michelle
    Beil, Emily
    Guffey, Danielle
    Ramirez, Andrea
    Yildirim-Toruner, Cagri
    Peckham-Gregory, Erin
    De Guzman, Marietta
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 358 - 359
  • [34] SOLUBLE TAM (TYRO3, AXL, MER) RECEPTORS AND GAS6 LIGAND IN PATIENTS WITH JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS (JS']JSLE)
    Liphaus, B. L.
    Palmeira, P.
    Lima, L.
    Silva, C. A.
    Goldenstein-Schainberg, C.
    Carneiro-Sampaio, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 381 - 381
  • [35] MONOCYTE CHEMOATTRACTANT PROTEIN 1 IS EXPRESSED FROM KIDNEY EPITHELIAL CELLS IN RESPONSE TO ACTIVATED MACROPHAGES IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JS']JSLE)
    Watson, L.
    Midgley, A.
    Ballantine, L.
    Jones, C. A.
    Holt, R. C.
    Marks, S. D.
    Pilkington, C.
    Tullus, K.
    Beresford, M. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 72 - 72
  • [36] SELF-REPORTED DISEASE ACTIVITY WAS THE MAIN DETERMINANT OF THE PERCEIVED IMPACT OF COVID-19 PANDEMIC ON ADOLESCENT AND YOUNG PATIENTS WITH JUVENILE DERMATOMYOSITIS (JDM) AND JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JS']JSLE)
    Khatun, Ayesha
    Wu, Wing Han
    Peng, Junjie
    Hennelly, Laura
    Sloan, Melanie
    Bosley, Michael
    Howard, Paul
    Jury, Liz
    Ciurtin, Coziana
    RHEUMATOLOGY, 2021, 60
  • [37] Brain magnetic resonance imaging (MRI) versus single photon emission topography (SPECT) in juvenile systemic lupus erythematosus (JS']JSLE) patients with and without central nervous system involvement.
    Prismich, G
    Hilario, MOE
    Sevillano, MM
    Schmutzler, KMRS
    Terreri, MT
    Goldenberg, J
    Lederman, H
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 957 - 957
  • [38] HOW THE ADULT CRISS WORKS IN PEDIATRIC JS']JSSC PATIENTS - RESULTS FROM THE JUVENILE SCLERODERMA INCEPTION COHORT
    Klotsche, J.
    Foeldvari, I.
    Kasapcopur, O.
    Adrovic, A.
    Torok, K.
    Stanevicha, V.
    Anton, J.
    Marrani, E.
    Terreri, M. T.
    Sztajnbok, F. R.
    Battagliotti, C.
    Berntson, L.
    Eleftheriou, D.
    Horneff, G.
    Nuruzzaman, F.
    Helmus, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1202 - 1202
  • [39] JUVENILE SYSTEMIC SCLEROSIS (JS']JSSC) PATIENTS WITH OVERLAP CHARACTERISTICS DO NOT HAVE MILD DISEASE. RESULTS FROM THE JS']JSSC INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM
    Foeldvari, I.
    Klotsche, J.
    Kasapcopur, O.
    Adrovic, A.
    Torok, K.
    Terreri, M. T.
    Sakamoto, A. P.
    Feldman, B.
    Stanevicha, V.
    Anton, J.
    Sztajnbok, F. R.
    Khubchandani, R.
    Alexeeva, E.
    Katsikas, M.
    Sawhney, S.
    Smith, V.
    Appenzeller, S.
    Avcin, T.
    Kostik, M.
    Lehman, T.
    Marrani, E.
    Schonenberg, D.
    Sifuentes-Giraldo, W. A.
    Vasquez-Canizares, N.
    Janarthanan, M.
    Moll, M.
    Nemcova, D.
    Patwardhan, A.
    Santos, M. J.
    Battagliotti, C.
    Berntson, L.
    Bica, B.
    Brunner, J.
    Cimaz, R.
    Reis, P. Costa
    Eleftheriou, D.
    Harel, L.
    Horneff, G.
    Johnson, S.
    Kaiser, D.
    Kallinich, T.
    Lazarevic, D.
    Minden, K.
    Nielsen, S.
    Nuruzzaman, F.
    Hetlevik, S. Opsahl
    Uziel, Y.
    Helmus, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 934 - 934
  • [40] Preliminary results from patients with metastatic urothelial carcinoma (UC) in a phase 2 study of JS']JS001, an anti-PD-1 monoclonal antibody.
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Si, Lu
    Tang, Bixia
    Yan, Xieqiao
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345